Conditions: Stroke Upper Limb Spasticity
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 42
Healthy volunteers: no

Brief summary:
The purpose of this study is to investigate if early administration (i.e. within 12 weeks after stroke) of Dysport® 500 U injections may delay the appearance or the progression of upper limb symptomatic spasticity.

Detailed description:

Arms:
arm 1: Dysport® 500U intramuscular injection arm 2: Placebo intramuscular injection

Interventions: intervention 1: Botulinum toxin type A intervention 2: Placebo
Intervention descriptions: intervention 1: Subjects to receive Dysport® 500U administered intramuscularly in the targeted upper limb. intervention 2: Placebo administered intramuscularly in the targeted upper limb.

Protocol document: